Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lisdexamfetamine for the Treatment of Severe Obesity in Children Aged 6 to 12 Years

NCT05416125 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT05416125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05416125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lisdexamfetamine for the Treatment of Severe Obesity in Children Aged 6 to 12 Years
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Completed
Start date
December 20, 2023
Completion date
June 23, 2026
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, childhood